Related Experiment Videos
Rhesus D genotyping in amniotic fluid
T H Müller1, S Gran, I Lammers
1DRK-Blutspendedienst Niedersachsen, Sachsen, Institut Oldenburg, Germany.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine
|January 1, 1996
Summary
Prenatal Rhesus D genotyping using PCR on amniotic fluid is crucial for Rhesus D-alloimmunized pregnancies. This study refines the method to enhance accuracy and minimize false-negative results in Rhesus D typing.
Area of Science:
- Molecular Biology
- Genetics
- Prenatal Diagnostics
Background:
- Rhesus D (RhD) genotyping via PCR on amniotic fluid is vital for managing RhD-alloimmunized pregnancies.
- Previous genotyping methods, such as those by Bennett et al. and Simsek et al., have reported misleading results, particularly with DVI variants.
- These inaccuracies stem from analyzing specific gene regions or size differences, highlighting the need for improved Rhesus D typing accuracy.
Purpose of the Study:
- To address limitations in existing Rhesus D genotyping methods for prenatal diagnosis.
- To propose a refined PCR strategy for Rhesus D genotyping to minimize false-negative results.
- To ensure reliable prenatal identification of Rhesus D status in alloimmunized pregnancies.
Main Methods:
- Utilized polymerase chain reaction (PCR) for Rhesus D genotyping on amniotic fluid samples.
- Developed an assay amplifying two distinct regions, including the 3'-terminal region of the RhD gene.
- Focused on improving accuracy for challenging samples, such as DVI variants.
Main Results:
- Identified issues with prior Rhesus D genotyping techniques, including those analyzing the 3'-terminal end and intron 4 size differences.
- Observed problems with DVI-variant samples in existing assays.
- The proposed method amplifies two regions of the RhD gene to reduce the risk of false negatives.
Conclusions:
- The refined Rhesus D genotyping method, by amplifying two regions including the 3'-terminal end, significantly minimizes the risk of false-negative results.
- This approach enhances the reliability of prenatal diagnosis for Rhesus D status.
- The rapid Rhesus D genotyping typically requires a minimal sample volume of 2 ml of amniotic fluid.